+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Diabetes Drugs Market Research Reports

Asia Pacific Biosimilar Insulin Glargine and Lispro Market Report and Forecast 2023-2031 - Product Thumbnail Image

Asia Pacific Biosimilar Insulin Glargine and Lispro Market Report and Forecast 2023-2031

  • Report
  • June 2023
  • 120 Pages
  • Asia Pacific
From
Diabetic Neuropathy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Diabetic Neuropathy Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
Diabetes Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Diabetes Drugs Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Diabetic Neuropathy Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Diabetic Neuropathy Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis

  • Report
  • May 2024
  • 93 Pages
  • Global
From
Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast - Product Thumbnail Image

Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast

  • Report
  • May 2024
  • 16 Pages
  • Global
From
Hyperinsulinemia (HI) - Competitive Landscape - Product Thumbnail Image

Hyperinsulinemia (HI) - Competitive Landscape

  • Report
  • January 2024
  • 69 Pages
  • Global
From
Painful Diabetic Neuropathy Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Painful Diabetic Neuropathy Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • February 2023
  • 32 Pages
  • Global
From
Diabetic Foot Ulcers Market Size, Share and Trends Analysis by Region, Treatment, Ulcers Type, End-user and Segment Forecast, 2022-2027 - Product Thumbnail Image

Diabetic Foot Ulcers Market Size, Share and Trends Analysis by Region, Treatment, Ulcers Type, End-user and Segment Forecast, 2022-2027

  • Report
  • November 2022
  • 100 Pages
  • Global
From
Nateglinide Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Nateglinide Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • April 2023
  • 74 Pages
  • Global
From
Islet Amyloid Polypeptide Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Islet Amyloid Polypeptide Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • August 2024
  • 84 Pages
  • Global
From
Pancreatic Beta Cell Protection Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Pancreatic Beta Cell Protection Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • December 2023
  • 117 Pages
  • Global
From
Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2029

  • Report
  • October 2020
  • 133 Pages
  • Global
From
Type 2 Diabetes Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029 - Product Thumbnail Image

Type 2 Diabetes Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029

  • Drug Pipelines
  • December 2022
  • 148 Pages
  • Global
From
South America Diabetes Drug Market Outlook, 2030 - Product Thumbnail Image

South America Diabetes Drug Market Outlook, 2030

  • Report
  • June 2025
  • 81 Pages
From
Diabetes Drugs Companies in China - Product Thumbnail Image

Diabetes Drugs Companies in China

  • Report
  • August 2024
  • 76 Pages
  • China
From
Type 2 Diabetes in the United States: Key Insights into Treatment Awareness & Satisfaction - Product Thumbnail Image

Type 2 Diabetes in the United States: Key Insights into Treatment Awareness & Satisfaction

  • Report
  • January 2024
  • 120 Pages
  • United States
Delayed Onset Type 1 Diabetes Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access - Product Thumbnail Image

Delayed Onset Type 1 Diabetes Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access

  • Report
  • March 2023
  • 26 Pages
  • Global
Jardiance - Product Thumbnail Image

Jardiance

  • Drug Pipelines
  • February 2019
  • 43 Pages
  • Global
From
Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1127 Pages
  • Global
From
Loading Indicator

The Diabetes Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat diabetes. Diabetes is a chronic condition that affects millions of people worldwide, and the drugs used to treat it can help to manage the symptoms and reduce the risk of complications. Commonly prescribed diabetes drugs include insulin, sulfonylureas, meglitinides, thiazolidinediones, and DPP-4 inhibitors. These drugs are used to help regulate blood sugar levels, reduce insulin resistance, and improve the body's ability to use insulin. Some of the major companies in the Diabetes Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the research, development, and marketing of diabetes drugs, and they are constantly striving to develop new and improved treatments for the condition. Show Less Read more